Sphera Funds Management’s Immunovant, Inc. Units IMVTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-94,500
Closed -$1.56M 118
2020
Q1
$1.56M Sell
94,500
-5,500
-6% -$106K 0.2% 59
2019
Q4
$2.49M Buy
+100,000
New +$2.15M 0.21% 72

Sphera Funds Management's IMVTU Position: Q2 2020 in Review

Sphera Funds Management sold out of Immunovant, Inc. Units (IMVTU) in Q2 2020, closing a stake of 94,500 shares — an estimated $1.56M sold.

Sphera Funds Management first reported a position in IMVTU in Q4 2019 and held it in 2 quarters. The position peaked at $2.49M in Q4 2019. 0 funds tracked by Wall St. Rank hold IMVTU as of Q2 2020.

  • Sphera Funds Management reported no remaining Immunovant, Inc. Units position as of Q2 2020 after selling out during the quarter.
  • Sphera Funds Management sold 94,500 Immunovant, Inc. Units shares in Q2 2020, an estimated $1.56M.
  • Sphera Funds Management first reported a position in Immunovant, Inc. Units in Q4 2019 and held it in 2 quarters.
  • Sphera Funds Management's Immunovant, Inc. Units position peaked at $2.49M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Units as of Q2 2020.

Based on Sphera Funds Management's 13F filing for Q2 2020, filed 13 Aug 2020.